Jennifer N Tran

USPTO Granted Patents = 20 (Patent Applications = 3)

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 4.8

ph-index = 8

Forward Citations = 369(Granted Patents)

Location History:

Branford, CT (US) (2000 - 2002)
Guilford, CT (US) (2001 - 2017)

Company Filing History:

Rib-x Pharmaceuticals, Inc.

Melinta Therapeutics, Inc.

patents

5. 6 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2017

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9550783 - Biaryl heterocyclic compounds and methods of making and using the same (2017-01-24),

2. 7705026 - Biaryl heterocyclic compounds and methods of making and using the same (2010-04-27),

3. 7456206 - Biaryl heterocyclic compounds and methods of making and using the same (2008-11-25),

4. 7148219 - Biaryl heterocyclic compounds and methods of making and using the same (2006-12-12),

5. 7074929 - Certain alkylene diamine-substituted heterocycles (2006-07-11),

6. 6969726 - Biaryl heterocyclic compounds and methods of making and using the same (2005-11-29),

7. 6696445 - Certain alkylene diamine-substituted heterocycles (2004-02-24),

8. 6566367 - Spiro[isobenzofuran-1,4′-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4′-piperidines (2003-05-20),

9. 6544996 - 1-phenyl-4-(1-[2-aryl]cyclopropyl) methylpiperazines: dopamine receptor ligands (2003-04-08),

10. 6506762 - Certain alkylene diamine-substituted heterocycles (2003-01-14),

11. 6486164 - 6-(4-arylalkylpiperazin-1-yl) benzodioxane and 6-(4-arylalkylpiperazin-1-yl) chromane derivatives: dopamine receptor subtype specific ligands (2002-11-26),

12. 6476038 - Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines (2002-11-05),

13. 6444819 - Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands (2002-09-03),

14. 6372743 - Certain alkylene diamine-substituted pyrazlo (1,5-a)-1,5-pyrimidines and pyrazolo (1,5-a) 1,3,5-triazines (2002-04-16),

15. 6333329 - 6-(4-arylalkylpiperazin-1-yl) benzodioxane and 6-(arylalkylpiperazin-1-yl) chromane derivatives: dopamine receptor subtype specific ligands (2001-12-25),

Title: The Contributions of Jennifer N Tran in the Field of Innovative Compounds

Introduction: Jennifer N Tran, based in Guilford, CT, is an esteemed inventor known for her significant contributions to the field of pharmaceuticals, particularly in the development of innovative biaryl heterocyclic compounds. With 20 patents to her name, her work has paved the way for new advancements in anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents.

Latest Patents: Among her latest innovations, Tran has developed a patented family of compounds characterized by both a biaryl moiety and at least one heterocyclic moiety. This invention specifically addresses the need for new agents in treating conditions related to infection, cancer proliferation, inflammation, and digestive disorders. The methods for making and using these compounds highlight her ability to merge complex chemistry with practical applications in medicine.

Career Highlights: Tran has made substantial strides throughout her career, notably during her tenure at Neurogen Corporation, where she applied her expertise in medicinal chemistry to push the boundaries of drug development. Her dedicated research has resulted in a suite of patents that reflect her innovative approach and commitment to improving therapeutic outcomes for patients.

Collaborations: During her journey, Jennifer has collaborated with notable professionals in the field such as Andrew Y Thurkauf and Philip Albert Carpino. These collaborations underscore the importance of teamwork in driving innovation and responding to complex challenges in pharmaceutical research.

Conclusion: Jennifer N Tran stands out as a key figure in her field, with her extensive patent portfolio affirming her role as a leading inventor. Her contributions not only enhance our understanding of biaryl heterocyclic compounds but also hold the potential for substantial impacts on future medical treatments. Through her innovative work and collaborations, she continues to inspire the next generation of scientists and inventors.

This text is generated by artificial intelligence and may not be accurate.